Core Viewpoint - Betaini (300957) reported a decrease in R&D expenses for the first three quarters of 2025, attributed to the orderly execution of R&D activities based on established plans and research progress [1] Group 1: R&D Activities - The company utilizes resources and advantages from its Yunnan Province specialty plant extraction laboratory platform and Betaini Research Institute [1] - Collaborative efforts with research institutes in Japan and France, as well as cutting-edge joint laboratory resources, are aimed at targeted research in various areas [1] - The R&D projects include fundamental theoretical research on specialty plants, innovative raw material development, raw material screening, efficacy cosmetic development, functional food development, medical device development, new drug development for skin, and packaging development [1] Group 2: R&D Investment Alignment - The company's R&D investment is closely aligned with its research directions and progress [1]
贝泰妮：有针对性地开展特色植物基础理论研究、创新原料研发等多维度深层次研发项目